Vitex (Chasteberry): The Definitive Guide

What is vitex?

Vitex, chasteberry or Vitex agnus-castus is a Mediterranean shrub whose ripe dried fruit is used in powders and extracts. It is not a hormone. Laboratory work suggests that some constituents can interact with dopamine-related signaling, but a proposed mechanism does not prove that a retail product “balances hormones.” [4], [5]

Clinical evidence is most developed for PMS. Even there, extract identity matters: the strictest meta-analysis excluded 18 of 21 trials because their products or reporting did not meet its criteria. [1]

Typical Vitex Protocols

There is no RDA, AI or established UL for vitex. A concentrated extract amount cannot be converted to berry powder without its drug-to-extract ratio and solvent.

Titration

No validated general self-titration is established. Changing an extract amount can change its pharmacology.

Timing

Named studies and the EMA preparation use once-daily exposure; a universal best clock time is not established.

Duration

PMS trials commonly followed several cycles. They do not establish indefinite use.

Stopping

No standard taper is established. New menstrual changes, pregnancy or significant adverse effects warrant stopping and clinical review.

What is vitex commonly used for?

Vitex is promoted for PMS, breast tenderness, PMDD, irregular cycles, elevated prolactin, infertility and menopause symptoms. The controlled evidence is concentrated in PMS. PMDD, fertility, luteal-phase and menopause claims require separate trials and should not inherit the PMS result. [1], [2]

Which form and label details matter?

1. Species and part: look for Vitex agnus-castus fruit, not a vague “women's blend.”
2. Extract identity: Ze 440, BNO 1095 and other extracts have different ratios and solvents.
3. Daily total: record the amount per tablet and number of tablets separately.
4. Combination ingredients: mixtures cannot assign an effect to vitex alone.
5. Reproductive context: pregnancy plans, cycle changes, hormone treatment and dopamine-active medicines belong in the same review.

What does the human evidence show?

Premenstrual symptoms

Csupor and colleagues found 21 clinical trials but retained only three double-blind, randomized, placebo-controlled trials with properly characterized products, totaling 520 participants. The pooled remission relative risk was 2.57 (95% CI 1.52–4.35). The sharp exclusion is part of the conclusion: much of the apparent literature cannot support precise product claims. [1]

The broader Verkaik review included 17 randomized trials and pooled 14. Thirteen reported positive results, but most had high risk of bias; placebo-controlled effects were extremely heterogeneous (I² 91%), and publication bias was suspected. The authors warned that the pooled effect probably overestimated the true effect. [2]

In Schellenberg's trial, 178 women were screened and 170 evaluated after Ze 440 or placebo once daily for three cycles. The prespecified six-symptom score and global assessments favored vitex; 52% versus 24% met the 50%-improvement responder definition. Seven mild adverse events were reported, four with vitex and three with placebo. [3]

Fertility, prolactin and other uses

Mechanistic hypotheses about pituitary dopamine signaling have encouraged fertility and prolactin claims. Current evidence does not establish vitex as treatment for infertility, a pituitary disorder, amenorrhea or menopause symptoms. These conditions can have causes that need diagnosis and should not be delayed by supplement use. [4], [5]

How might it work?

Vitex fruit contains diterpenes, flavonoids and iridoids. Dopamine D2-receptor activity and altered prolactin secretion are proposed mechanisms for certain extracts. Human clinical outcomes cannot be inferred from receptor or cell studies, and constituent profiles vary with extraction. [4], [5]

What are the risks and interactions?

Reported adverse effects are usually mild and reversible and include nausea, headache, gastrointestinal symptoms, menstrual changes, acne, itching and rash. The evidence base is not designed to rule out uncommon or long-term harms. [4]

Avoid use during pregnancy and lactation because safety is inadequate and reproductive effects are plausible. Dopamine antagonists and agonists, antipsychotic or Parkinson medicines, hormonal medicines and fertility treatment deserve pharmacist or prescriber review. Theoretical interaction does not prove that every combination causes harm, but it rules out casual self-experimentation. [4], [5]

Seek urgent care for facial or throat swelling, breathing difficulty, fainting, severe rash or heavy bleeding. Pregnancy, new nipple discharge, severe headache or visual change needs prompt assessment rather than self-treatment for “high prolactin.”

Legal status in the United States and Canada

In the United States, vitex supplements are not FDA-approved treatments for PMS, PMDD, infertility or hyperprolactinemia.

In Canada, licensed natural health products have an NPN and product-specific label conditions. An NPN does not make every extract interchangeable or establish treatment of infertility.

What should you monitor?

Record the exact extract, amount per unit, daily total, start and stop dates, cycle dates, symptom scale, pregnancy possibility and all medicines. Evaluate trends across prospectively recorded cycles; a single good or difficult cycle does not establish causation.

What happens when you stop?

A predictable withdrawal syndrome is not established and no evidence-based taper is known. Symptoms may return to their untreated pattern. A delayed or absent period should prompt pregnancy testing and appropriate care rather than automatic restart.

How should it be stored?

Keep tablets and capsules closed, dry, away from heat and out of children's reach. Follow the finished-product expiry date and discard products with damaged seals or changed odor or appearance.

How does vitex compare with other approaches?

Vitex is not an SSRI, hormonal contraceptive, fertility medicine or dopamine-active prescription drug. Those options have different evidence, risks and clinical roles. Calcium, magnesium and other supplements have separate evidence and cannot be compared by milligrams.

Prospective symptom charting and assessment for anemia, thyroid disease, pregnancy, medication effects or another gynecologic cause may be more useful than switching among uncharacterized blends.

What do public communities add?

Public reports highlight cycle changes, headache, skin changes and the difficulty of comparing extracts. They cannot confirm ovulation, prolactin normalization, pregnancy safety or product identity. Anecdotes were not used to establish schedules.

Common questions

Does vitex balance hormones?

That phrase is too broad to test. Trials measured defined PMS symptoms with named extracts; they did not show general normalization of hormones. [1], [3]

Does vitex help PMS?

There is a signal from a small set of characterized-extract trials. Bias, heterogeneity and product specificity keep the conclusion cautious. [1], [2]

Does it treat PMDD?

PMDD is a distinct clinical diagnosis. Vitex should not replace assessment or evidence-based treatment.

Can vitex improve fertility?

No reliable evidence establishes it as fertility treatment. It can also complicate interpretation of cycle changes.

Can I use it during pregnancy or breastfeeding?

Avoid it unless a qualified clinician has a specific reason; safety is inadequate and expert reviews advise against use. [4]

Does 20 mg equal berry powder?

No. That amount belongs to a specified concentrated extract. Drug-to-extract ratio and solvent determine what it represents. [5]

Does vitex interact with medicines?

Dopamine-active, hormonal and fertility medicines need review. Clinical interaction data are limited, so absence of a documented case is not proof of compatibility. [4]

Should it be cycled?

No evidence-based on/off cycling schedule is established.

Glossary

Terms used in this guide.

PMS

Premenstrual syndrome: recurring physical or emotional symptoms in the luteal phase that resolve around menstruation.

PMDD

Premenstrual dysphoric disorder, a clinically diagnosed severe mood-predominant premenstrual condition.

Responder

A participant who meets a prespecified improvement threshold; the Schellenberg trial used at least 50% symptom reduction.

Drug-to-extract ratio

The quantity of starting plant material used to make one quantity of extract.

Prolactin

A pituitary hormone involved in lactation and reproductive signaling; abnormal results require clinical interpretation.

Titration

Changing an amount in planned steps. No general vitex self-titration is established.

How this guide was researched

This draft prioritized a strict 2019 meta-analysis, the broader 2017 review, the pivotal Ze 440 primary trial, a systematic safety review and the EMA monograph and assessment. Searches kept named extracts, outcomes and evidence access levels separate.

Corrections to the legacy manuscript include removing universal dose claims, narrowing efficacy to characterized PMS products, separating fertility and prolactin marketing from controlled evidence, and strengthening pregnancy and dopamine-medicine cautions. Evidence was refreshed October 9, 2026.

How this guide was made

The source ledger records preparation, population, schedule, outcome and access level. Draft status means scientific, French-parity, asset and rendered-page review remain separate gates.

Sources

Related guides